NPs Basic Information

Name
Chartarlactam B
Molecular Formula C28H39NO6
IUPAC Name*
5-[(3R,4aS,7R,8R,8aS)-3,4'-dihydroxy-4,4,7,8a-tetramethyl-6'-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrofuro[2,3-e]isoindole]-7'-yl]pentanoic acid
SMILES
C[C@@H]1CC[C@@H]2[C@@]([C@@]13CC4=C(C=C5C(=C4O3)CN(C5=O)CCCCC(=O)O)O)(CC[C@H](C2(C)C)O)C
InChI
InChI=1S/C28H39NO6/c1-16-8-9-21-26(2,3)22(31)10-11-27(21,4)28(16)14-18-20(30)13-17-19(24(18)35-28)15-29(25(17)34)12-6-5-7-23(32)33/h13,16,21-22,30-31H,5-12,14-15H2,1-4H3,(H,32,33)/t16-,21+,22-,27+,28-/m1/s1
InChIKey
OPCQWQMQPFYESC-SELUXCBJSA-N
Synonyms
Chartarlactam B; CHEMBL3104965
CAS NA
PubChem CID 76335578
ChEMBL ID CHEMBL3104965
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Isoindoles and derivative
        • Subclass: Isoindolines
          • Direct Parent: Isoindolones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 485.6 ALogp: 4.1
HBD: 3 HBA: 6
Rotatable Bonds: 5 Lipinski's rule of five: Accepted
Polar Surface Area: 107.0 Aromatic Rings: 5
Heavy Atoms: 35 QED Weighted: 0.507

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.631 MDCK Permeability: 0.00000825
Pgp-inhibitor: 0.625 Pgp-substrate: 0.669
Human Intestinal Absorption (HIA): 0.035 20% Bioavailability (F20%): 0.837
30% Bioavailability (F30%): 0.644

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.044 Plasma Protein Binding (PPB): 95.37%
Volume Distribution (VD): 0.363 Fu: 4.88%

ADMET: Metabolism

CYP1A2-inhibitor: 0.07 CYP1A2-substrate: 0.571
CYP2C19-inhibitor: 0.017 CYP2C19-substrate: 0.215
CYP2C9-inhibitor: 0.375 CYP2C9-substrate: 0.812
CYP2D6-inhibitor: 0.054 CYP2D6-substrate: 0.197
CYP3A4-inhibitor: 0.046 CYP3A4-substrate: 0.066

ADMET: Excretion

Clearance (CL): 6.397 Half-life (T1/2): 0.685

ADMET: Toxicity

hERG Blockers: 0.077 Human Hepatotoxicity (H-HT): 0.324
Drug-inuced Liver Injury (DILI): 0.081 AMES Toxicity: 0.113
Rat Oral Acute Toxicity: 0.574 Maximum Recommended Daily Dose: 0.957
Skin Sensitization: 0.621 Carcinogencity: 0.228
Eye Corrosion: 0.003 Eye Irritation: 0.085
Respiratory Toxicity: 0.907
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC002992 0.810 D00AEQ 0.282
ENC002034 0.810 D03SXE 0.253
ENC003008 0.676 D04GJN 0.252
ENC001965 0.649 D0I2SD 0.252
ENC005396 0.648 D0R7JT 0.252
ENC002673 0.648 D0IX6I 0.246
ENC003020 0.648 D0KR5B 0.246
ENC005398 0.632 D0M4WA 0.245
ENC003552 0.606 D05RXI 0.243
ENC002995 0.587 D04VIS 0.242
*Note: the compound similarity was calculated by RDKIT.